Dexmethylphenidate - PDFSEARCH.IO - Document Search Engine

Dexmethylphenidate
Results: 53

#	Item
21	DUR Committee Agenda October 8th, 2013 Office of MaineCare Services, Department of Health and Human Services Augusta Civic Center Androscoggin/Aroostook/Cumberland Room- Augusta, Maine 1:00 to 6:00 pm Add to Reading List Source URL: mainecarepdl.org Language: English - Date: 2013-11-12 08:36:26 Chemistry Nootropics Angiotensin II receptor antagonists Dexmethylphenidate Stimulants Niacin/simvastatin Certolizumab pegol Sitagliptin/metformin Adderall Pharmacology Combination drugs Medicine
22	Microsoft Word - 15 Day Limits Drug List.doc Add to Reading List Source URL: mainecarepdl.org Language: English - Date: 2012-03-06 15:01:02 Pharmacology Nootropics Piperidines Stimulants Ethers Methylphenidate Oxymorphone Adderall Dexmethylphenidate Chemistry Organic chemistry Alcohols
23	>Ì>Ê/ÝV}ÞÊÀ}À> 1°-°Êi«>ÀÌiÌÊvÊi>ÌÊ>`ÊÕ>Ê-iÀÛViÃ iÌiÀÊÀÊ/iÊ Û>Õ>ÌÊ"vÊ,ÃÃÊ /ÊÕ>Ê,i«À`ÕVÌ Add to Reading List Source URL: ntp.niehs.nih.gov Language: English* - Date: 2014-09-09 12:53:23 Pharmacology Chemistry Nootropics Piperidines Enantiopure drugs Methylphenidate Attention deficit hyperactivity disorder Pemoline Dexmethylphenidate Medicine Stimulants Attention-deficit hyperactivity disorder
24	DUR Committee Agenda October 8th, 2013 Office of MaineCare Services, Department of Health and Human Services Augusta Civic Center Androscoggin/Aroostook/Cumberland Room- Augusta, Maine 1:00 to 6:00 pm Add to Reading List Source URL: www.mainecarepdl.org Language: English - Date: 2013-11-12 08:36:26 Chemistry Nootropics Angiotensin II receptor antagonists Dexmethylphenidate Stimulants Niacin/simvastatin Certolizumab pegol Sitagliptin/metformin Adderall Pharmacology Combination drugs Medicine
25	Clinical Care Guidelines for: Attention Deficit Hyperactivity Disorder OBJECTIVE Guide the appropriate diagnosis and treatment of ADHD in the MDwise population as it is the second most common chronic condition in childr Add to Reading List Source URL: www.mdwise.org Language: English - Date: 2014-03-24 11:51:04 Attention-deficit hyperactivity disorder Chemistry Amphetamines Stimulants Piperidines Methylphenidate Attention deficit hyperactivity disorder Adderall Dexmethylphenidate Medicine Nootropics Pharmacology
26	1 Methylphenidate Regulatory History Pediatric Advisory Committee Meeting June 30, 2005 Add to Reading List Source URL: www.fda.gov Language: English - Date: 2005-07-07 15:31:29 Pharmacology Organic chemistry Chemistry Attention-deficit hyperactivity disorder Drug culture Methylphenidate Dexmethylphenidate Attention deficit hyperactivity disorder management Piperidines Stimulants Nootropics
27	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FOCALIN XR safely and effectively. See full prescribing information for FOCALIN XR. FOCALIN XR (dexmethylphenidate h Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2011-12-02 14:39:53 Nootropics Stimulants Piperidines Attention-deficit hyperactivity disorder Drug culture Methylphenidate Dexmethylphenidate Venlafaxine Attention deficit hyperactivity disorder Medicine Chemistry Pharmacology
28	Microsoft Word - 15 Day Limits Drug List.doc Add to Reading List Source URL: www.mainecarepdl.org Language: English - Date: 2012-03-06 15:01:02 Pharmacology Nootropics Piperidines Stimulants Ethers Methylphenidate Oxymorphone Adderall Dexmethylphenidate Chemistry Organic chemistry Alcohols
29	Review: Death with the concomitant use of clonidine or guanfacine and amphetamine/dextroamphetamine or dexmethylphenidate or dextroamphetamine or lisdexamfetamine or methylphenidate Add to Reading List Source URL: www.fda.gov Language: English Stimulants Attention-deficit hyperactivity disorder Nootropics Amphetamines Antihypertensive agents Methylphenidate Clonidine Adderall Dextroamphetamine Pharmacology Chemistry Medicine
30	21802S014 Focalin Clinpharm PREA Add to Reading List Source URL: www.fda.gov Language: English Piperidines Chemistry Organic chemistry Attention-deficit hyperactivity disorder Dexmethylphenidate Methylphenidate Novartis IntelliPharmaCeutics Nootropics Stimulants Pharmacology

UPDATE